Guy Braunstein
Director/Board Member bij Actelion Clinical Research, Inc.
Vermogen: 612 125 $ op 31-03-2024
Profiel
Guy Braunstein is currently the Director at Actelion Clinical Research, Inc. He previously held positions as the Director-Europe Development & Medical Affairs at Chiron Corp., Medical Director at Fisons Pharmaceuticals, Executive VP & Head-Global Clinical Development at Actelion Ltd., and Chief Medical Officer at Merck Serono SA. He also worked at Serono International SA as a Chief Medical Officer.
Dr. Braunstein is currently the Chief Medical Officer & Executive Vice President at Idorsia Ltd.
He holds a doctorate degree from Université Paris 1 Panthéon-Sorbonne.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IDORSIA LTD.
0.10% | 31-12-2022 | 194 958 ( 0.10% ) | 612 125 $ | 31-03-2024 |
Actieve functies van Guy Braunstein
| Bedrijven | Functie | Begin |
|---|---|---|
| Actelion Clinical Research, Inc. | Director/Board Member | - |
Eerdere bekende functies van Guy Braunstein
| Bedrijven | Functie | Einde |
|---|---|---|
| IDORSIA LTD | Chief Tech/Sci/R&D Officer | 31-03-2024 |
| ACTELION | Corporate Officer/Principal | 01-01-2017 |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Corporate Officer/Principal | 01-01-2009 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01-01-2003 |
| Fisons Pharmaceuticals | Corporate Officer/Principal | 01-01-1996 |
Opleiding van Guy Braunstein
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IDORSIA LTD | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
| Fisons Pharmaceuticals | |
| Serono International SA | |
| Actelion Clinical Research, Inc. |
